Cogentin and Encephalitis autoimmune - a phase IV clinical study of FDA data

Summary:

Encephalitis autoimmune is reported as a side effect among people who take Cogentin (benztropine mesylate), especially for people who are female, 50-59 old, also take Zopiclone, and have Psychotic disorder.

The phase IV clinical study analyzes which people have Encephalitis autoimmune when taking Cogentin. It is created by eHealthMe based on reports of 7,418 people who have side effects when taking Cogentin from the FDA, and is updated regularly.

What is Cogentin?

Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.

What is Encephalitis autoimmune?

Encephalitis autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain) is found to be associated with 112 drugs and 146 conditions by eHealthMe. Check the latest studies of Encephalitis autoimmune.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

7,418 people reported to have side effects when taking Cogentin.
Among them, 15 people (0.2%) have Encephalitis autoimmune.

Could Cogentin cause Encephalitis autoimmune?

Among these 15 people:

What is the gender of people who have Encephalitis autoimmune when taking Cogentin? *

female: 100 %
male: 0.0 %

What is the age of people who have Encephalitis autoimmune when taking Cogentin? *

What are other drugs people take besides Cogentin? *

What are other side effects people have besides Encephalitis autoimmune? *

White Blood Cells Urine Positive: 15 people, 100.00%
Rashes (redness): 15 people, 100.00%
Glomerular Filtration Rate Decreased: 15 people, 100.00%
Fever: 15 people, 100.00%
Eosinophil Count Abnormal: 15 people, 100.00%
Aspartate Aminotransferase Increased: 15 people, 100.00%
Alanine Aminotransferase Increased: 15 people, 100.00%

What are the existing conditions these people have? *

Psychotic Disorder: 14 people, 93.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cogentin and have Encephalitis autoimmune?

- Check whether Encephalitis autoimmune is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cogentin:

Cogentin (7,692 reports)

Browse all side effects of Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalitis autoimmune:

Encephalitis autoimmune (112 drugs)

Browse all the conditions that are associated with Encephalitis autoimmune:

Encephalitis autoimmune (146 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benztropine mesylate (the active ingredients of Cogentin) and Cogentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.